Sentences with phrase «for multiple myeloma»
An experimental immunotherapy treatment for multiple myeloma from a biotech company in China captured wide...
healthnewsreview.org
This page features information on multiple myeloma and immunotherapy clinical trials for multiple myeloma patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to people with multiple myeloma.
-- Poseida Therapeutics released very early data from a Phase 1 study of its CAR - T cell therapy for multiple myeloma.
The UPenn team has already tested this strategy in a small clinical trial for multiple myeloma.
Another major avenue of immunotherapy for multiple myeloma is adoptive cell transfer.
Due to the gaps in knowledge and the many unresolved questions, IQWiG still regards the use of certain forms of SCT for multiple myeloma to be acceptable only in the context of clinical studies.
Precious Cat Litter has teamed up with the Multiple Myeloma Research Foundation (MMRF) for its #CatsAgainstCancer campaign, which aims to raise awareness and find a cure for multiple myeloma, a rare form of blood cancer.
«Based on our finding that being overweight or obese is a risk factor for multiple myeloma in MGUS patients, and since extra weight is a modifiable risk factor, we hope that our results will encourage intervention strategies to prevent the progression of this condition to multiple myeloma as soon as MGUS is diagnosed,» Chang said.
«Immune therapy might be effective for multiple myeloma.»
Investors have been concerned about patent challenges to its long - time cash cow Revlimid for multiple myeloma and the surprise failure last week of an experimental Crohn's disease drug touted as a future multibillion - dollar product.
«Several major advances in recent years have been good news for multiple myeloma patients, but those new drugs only target terminally differentiated cancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego Health.
An update search enlarged the pool of study data, but did not change the content of the conclusion of the benefit assessment of stem cell transplantation (SCT) for multiple myeloma conducted in 2012.
«Stem cell transplantation for multiple myeloma: New data did not change conclusion.»
Myc inhibitors are thought to be promising treatments for multiple myeloma because they shut down a gene required for cell proliferation.
The researchers suspected Myc inhibitors would be a good treatment strategy for multiple myeloma if effective levels of the compound could be maintained in the circulation and delivered to the right cells.
«Today, we have half a dozen drugs for multiple myeloma that can put patients into remission,» said Tomasson, who treats patients with multiple myeloma at Siteman Cancer Center at Barnes - Jewish Hospital and Washington University School of Medicine.
That trend is problematic considering that African - Americans — the most at - risk population for multiple myeloma — have different genetics that can affect how this type of cancer progresses and what kind of targeted therapies are most effective, said Zarko Manojlovic, lead author of the study.
A new study published online by JAMA Oncology examines the assessment of minimal residual disease in patients newly treated for multiple myeloma as a factor in survival outcomes.
«In many hospitals, doctors have abandoned the use of allografts for multiple myeloma due to the risk of toxicity and relapse.
«Personalized drug screening on horizon for multiple myeloma patients.»
«This is an important step in immunotherapy research for multiple myeloma, a tough - to - beat cancer that is largely incurable, with a five - year survival rate of approximately 50 percent — highlighting the need for new approaches to improve therapeutic options including after an ASCT,» said Edward Stadtmauer, MD, a professor of Medicine and section chief of Hematologic Malignancies in the ACC, and co-lead author.
Treatment with carfilzomib for multiple myeloma was associated with increased incidence of cardiovascular adverse events, especially with higher doses.
No Place Like Home Rebecca Zoltoski was the first patient at the University of Chicago Medicine to undergo a blood and bone marrow stem cell transplant as an outpatient for her multiple myeloma.
Lynx Biosciences, a business aiming to refine treatment decisions for multiple myeloma, took the life science prize at the Governor's Business Plan Contest during the 14th annual Wisconsin Entrepreneurs» Conference in Madison.
Stem Cells Make Bone Marrow Cancer Resistant to Treatment Scientists at the Johns Hopkins Kimmel Cancer Center provided evidence that cancer stem cells for multiple myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatments.
Independent, up - to - date news and information for the multiple myeloma community.
When Kathy was diagnosed, Dr. Elsey saw it as a challenge to get involved and help find a cure not only for multiple myeloma, but for all cancers.
These include Onyx Pharmaceutical Inc.'s Kyprolis for multiple myeloma, Roche's Zelboraf for melanoma and Pfizer's Xalkori.
«Three studies point to effectiveness of new therapies for multiple myeloma.»
In January 2012, IQWiG presented a final report and a supplementary working paper on the benefit of SCT for multiple myeloma, for which the last search for studies had been conducted in January 2011.
There is currently no cure for multiple myeloma, so life insurance approval may prove difficult.
TG - 0054 (structure not disclosed publicly) is an injectable small molecule CXCR4 antagonist that is currently in phase I / II clinical trials for multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease.
Earlier this month, the FDA approved two other treatments for multiple myeloma, including another kind of monoclonal antibody drug (the same class of drug that elotuzumab is in).
The company is developing CAR T - cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases.
According to Loncar, U.S. pharma giant Johnson & Johnson (jnj) and Danish biotech partner Genmab stood above their peers during the conference with stellar new data for Darzalex, a treatment for multiple myeloma (a rare blood cancer) that was first approved last year.
In July the FDA approved Onyx's Kyprolis as a treatment for multiple myeloma, a type of blood cancer.
Other CAR - T cell therapies are in testing, including a treatment for multiple myeloma.
«Thanks to a deeper understanding of cancer biology, we have a potential new targeted therapy for multiple myeloma, and can better tailor treatment for kids with Wilms tumor.
For multiple myeloma and plasmacytoma, other risk factors include the following:
«This is an opportunity for us to raise awareness for an organization that is making great strides toward finding a cure and advancing treatments for multiple myeloma,» said Dr. Bruce Elsey, co-founder of Precious Cat Litters.
From Pet Scan for Multiple Myeloma to Canine Cancer From Pet Scan for Multiple Myeloma to Dog Health Guide Home